{"title": "PDF", "author": "PDF", "url": "http://webdoc.sub.gwdg.de/ebook/diss/2003/fu-berlin/2002/108/Appendices.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "                                                                                                                                             Appendices 264 \n8. Appendices \n8.1. Appendix A: Comparison of Berlin and Mainz Patients \n \nDifferences between Berlin and Mainz pa tients, as tested by means of uni- and \nmultivariate procedures, were few. Tested sets of variables included (a) \nsociodemographic criteria (see Table A1), (b) general health, (see Table A2), (c) \nophthalmic factors (see Table A3), and (d) main variables under study. \nFor the large inequality of cellsizes (Mainz : Berlin = 1 : 4.24), tests of homogeneity of \nvariances and covariances were monitored closely. \nUsing chi-square tests, no significant diffe rences between Berlin and Mainz patients \nwere found for any of the tested sociodemographic variables (see Table A1). \n \nTable A1 \nComparison of Sociodemographic Characteristics Berlin Versus Mainz \nCharacteristic Berlin \n \n \n(n=89) Mainz \n \n \n(n= 21) t/\u03c72 df p \nAge (yrs) \nM \nSD \nRange  \n  \n71.38 \n8.57 \n43 yrs to 89 yrs  \n72.62 \n10.47 \n56 yrs to 87 yrs  \n \n \n-.57  \n \n \n108  \n \n \n.57 \nSex \nMale \nn (%) \n \nFemale  \nn (%) \n  \n \n38 (42.7) \n \n \n51 (57.3)  \n \n10 (47.6) \n \n \n11 (52.4)  \n \n \n \n.17  \n \n \n \n1  \n \n \n \n.68 \nMarital Status \nMarried \n               n (%) \n                \nWidowed \n               n (%) \n                \nDivorced \n               n (%) \n                \nSingle \n               n (%) \n                \nMissing  n (%)              \n \n49 (55.1) \n \n \n27 (30.3) \n \n \n4 (4.5) \n \n \n8 (9.0) \n \n1 (1.1)  \n \n14 (66.7) \n \n \n5 (23.8) \n \n \n2 (9.5) \n \n \n- \n \n-  \n \n.84 \n \n \n.37 \n \n \n.81 \n \n \n2.1  \n \n1 \n \n \n1 \n \n \n1 \n \n \n1  \n \n.36 \n \n \n.53 \n \n \n.37 \n \n \n.15 \n                           (Table continued) \n Appendi ces 265 \nTable A1 (continued) \nCharacteristic Berlin \n \n \n(n=89) Mainz \n \n \n(n= 21) t/\u03c72 df p \nYears of Education a \n \nup to 9 yrs  \n                  n (%) \n                   \n10 yrs \n                  n (%) \n                    \n12 to13 yrs  \n                  n (%) \n                   \nMissing \n                  n (%) \n                    \n \n \n41 (46.1) \n \n \n26 (29.2) \n \n \n21 (23.6) \n \n \n1 (1.1)  \n \n \n11 (52.4) \n \n \n4 (19.0) \n \n \n6 (28.6) \n \n \n-  \n \n \n.23 \n \n \n.94 \n \n \n.20  \n \n \n1 \n \n \n1 \n \n \n1  \n \n \n.63 \n \n \n.33 \n \n \n.65 \nResidence \n \nPrivate \n                 n (%) \n                  \nInstitutionalized \n                 n (%) \n                  \nElse \n                 n (%) \n                  \nMissing \n                 n (%) \n                   \n \n \n81 (93.1) \n \n \n5 (5.6) \n \n \n1 (1.1) \n \n \n2 (2.2)  \n \n \n21 (100) \n \n \n- \n \n \n- \n \n \n-  \n \n \n1.53 \n \n \n1.27 \n \n \n.24  \n \n \n1 \n \n \n1  \n \n \n.22 \n \n \n.26 \n \n \n.61 \nEmployment Status \n \nRetired \n                 n (%) \n                  \nWorking \n                 n (%) \n                  \nMissing \n                 n (%) \n \n                  \n \n \n81 (91.0) \n \n \n7 (7.9) \n \n \n1 (1.1)  \n \n \n \n20 (95.2) \n \n \n1 (4.8) \n \n \n-  \n \n \n \n \n \n.25 \n \n \n  \n \n \n \n \n \n1 \n  \n \n \n \n \n \n.61 \n \nNote.  T and chi-square tests pertain to differences between Berlin and Mainz patients. \n \nConcerning general health status, Berlin patients on average reported one more chronic \ndisease than Mainz patients. Also, Mainz pa tients were significantly happier with their \nhealth in general (see Table A2). \n \n \n \n                                                                                                                                              Appendices 266 \nTable A2 \nGeneral Health Indicato rs: Berlin versus Mainz \nCharacteristic Berlin \n(n=89) Mainz \n(n= 21) t df p \nMultimorbidity  \nM (SD) \nRange  \n  \n2.72 (2.20) \n0 to 9  \n1.75 (1.30) \n0 to 5  \n2.63  \n51.21a  \n.01 \nGeneral Health \nSatisfaction \nM (SD) \nRange \n  \n \n1.87 (.88) \n0 to 4  \n \n2.67 (.86) \n1 to 4  \n \n-3.75  \n \n108  \n \n.000 \nNote.  a: Equal variances not assumed (Levene F(108)= 5.72, p=.02). T tests pertain to differen- \nces between Berlin and Mainz patients. \n \n \nWith respect to ophthalmic history variables, Berlin patients had slightly better pre-\nsurgical vision in the eye operated on. Al so, among Mainz patients, no minor post- \nsurgical complications occurred. A comparison between anesthesiological methods was refrained from, since Mainz patients could only receive invasive types of anesthesia. \n \nTable A3 \nComparison of Visual Impairment in Berlin and Mainz Patients \nCharacteristic Berlin \n \n(n= 89) Mainz \n \n(n=21) t/\u03c72 df p \nSubjective Visual Impairment  \nM (SD) \nRange  \n  \n2.19 (.69) \n1 to 4 \n  \n2.19 (.60) \n1 to 3 \n  \n.003 \n \n  \n108  \n.997 \nDistance visual acuity pre-surgery \n \nEye (operated on) \nM (SD) \nRange \n \nEye (other)  \nM (SD) \nRange \n  \n \n \n.45 (.23) \n0 to 1 \n \n \n.66 (.21) \n.03 to 1 \n  \n \n \n.34 (.19) \n0 to .7 \n \n \n.60 (.25) \n.20 to 1 \n  \n \n \n2.03 \n \n \n \n1.22  \n \n \n108 \n \n \n \n108  \n \n \n.045 \n \n \n \n.224 \nDistance visual acuity post-surgery \n \nEye (operated on) \nM (SD) \nRange \n  \n \n \n.75 (.21) \n.03 to 1 \n  \n \n \n.70 (.22) \n.10 to 1 \n  \n \n \n \n.860  \n \n \n \n108  \n \n \n \n.392 \nChange in distance visual acuity \npost-surgery \nM (SD) \nRange   \n \n.30 (.23) \n-.05 to .90  \n \n.37 (.24) \n.00 to .90  \n \n-1.18  \n \n108  \n \n.240 \n                           (Table continued) Appendi ces 267 \nTable A3 (cotinued) \nCharacteristic Berlin \n \n(n= 89) Mainz \n \n(n=21) t/\u03c72 df p \nPrevious Cataract Surgery \n \nNo \nn (%) \n \nYes \nn (%) \n  \n \n \n50 (56.2) \n \n \n39 (43.8) \n  \n \n \n10 (47.6) \n \n \n11 (52.4)  \n \n \n \n.50  \n \n \n \n1  \n \n \n \n.479 \nMinor Post-surgical Complications \n \nNo \nn (%) \n \nYes \nn (%) \n \nMissing \nn (%)   \n \n \n69 \n \n \n16 \n \n \n \n4 (4.5)  \n \n \n21 \n \n \n- \n \n \n \n-  \n \n \n \n3.30  \n \n \n \n1  \n \n \n \n.07 \nNote.  T and chi-square tests pertain to differences between Berlin and Mainz patients. \n \n \n \nConcerning major variables under study multivaria te analyses of variance and t tests for \nindependent samples were conducted for the following sets of variables at the first \nmeasurement point only: (a) personality traits  (N, E, O), (b) situation-specific coping \ncontent scales (Focus on Positive, Seek ing Support, Active Coping, and Denial/Self-\nBlame coping), (c) content-free features of  coping (situation-specific selective coping \nand total range of coping), (d) affect vari ables (Positive and Negative Affect), (e) life \nsatisfaction, and (f) functional status. Wilk's  lambdas indicated multivariate difference \nbetween Berlin and Mainz with respect to personality traits (N, E, O) only (Wilk's \u03bb \nF(3, 106) = 3.88, p = .01, partial  \u03b72 = .10). Both tests for equality of variance-covariance \nwere non-significant, suggesting reliability of  F-tests despite widely discrepant cell-\nsizes. Univariate F-tests revealed a signifi cant impact of the \"hospital\" variable on \nExtraversion ( F(1, 108) = 9.61, p = .002, partial \u03b72 = .08). However, because of \nintercorrelations between independent variable s, the impact of the independent variable \non each dependent variable was tested once again using Roy-Bargman stepdown \nanalysis with univariate F-prioritization (f or details, see Section 4.1.8.). Homogeneity of \nregression was achieved for all components of  the stepdown analysis. According to F-\nprioritization, Extraversion was given highest  priority, yielding univariate results ( F(1,                                                                                                                                              Appendices 268 \n108) = 9.61, p = .002, partial \u03b72 = .08) which indicated a highe r mean Extraversion score \nfor patients treated at the Mainz hospital ( M = 2.48, SE = .12, n = 21) versus Berlin \npatients (M  = 2.08, SE = .06, n = 89). Openness to Experience and Neuroticism were \nentered next, but stepdown analyses did not reveal further differences between Berlin \nand Mainz patients. One other significan t difference was found concerning vision-\nrelated limitations experienced at t1 ( t(108) = 2.24, p = .03). Regarding this functional \nindicator, Berlin patients ( M = 1.81, SD = .88) reported slightly more vision-dependent \nlimitations than Mainz patients ( M = 1.33, SD = .85). However, all revealed differences \nwere small, amounting to just less than three-quarters of a standard deviation. \n \nOverall, differences between Berlin and Mainz patients pertained to their general health \nstatus, with patients from Mainz being self-reportedly healthier on both measures. \nMoreover, Mainz patients were slightly mo re extraverted and felt less limited while \nperforming vision-dependent activities than th eir Berlin counterparts. On none of the \n(t1) sociodemographic variables, affect measures, situation-specific coping responses (content or content-free), or most of th e ophthalmic data did Mainz patients differ \nsignificantly from Berlin participants. \n Appendi ces 269 \n8.2. Appendix B: Central Constructs \n \nTable B1 \nCentral Constructs: Descriptive Statistics \n  \nMean  \nSD  \nMin   \nMax  \nSkew (SE)  \nKurt (SE)  \n\u03b1 \n \nMajor Predictors        \n \nCoping \nSituation-Specific (t1)        \nFocus on Positive \n 2.25 .60 1 3.50 .03 (.23) -.28 (.46) .70 \nSeeking Support \n 1.81 .60 1 4 .86 (.23) .97 (.46) .73 \nActive Coping \n 1.77 .68 1 4 .97 (.23) .56 (.46) .74 \nEvasive Coping \n 1.35 .37 1 2.73 1.42 (.23) 2.15 (.46) .61 \nContent-Free Features of \nCoping  \nSituation-Specific         \nSelective Coping \n .38 .35 .02 2.02 2.03 (.23) 5.07 (.46) - \nRange of Coping \n 2.57 1.08 .00 4 -.46 (.23) -.46 (.46) .57 \n \nCoping \nDispositional (t4)        \nFocus on Positive/D \n 2.37 .65 1 3.50 -.16 (.25) -.52 (.49) .76 \nSeeking Support/D \n 1.86 .63 1 4 .72 (.25) .26 (.49) .76 \nActive Coping/D \n 2.07 .80 1 4 .31 (.25) -.91 (.49) .81 \nEvasive Coping/D \n 1.43 .45 1 3.30 1.72 (.25) 3.96 (.49) .70 \nContent-Free Features of Coping  \nDispositional        \nSelective Coping/D \n .46 .39 .00 2 1.52 (.25) 2.58 (.49) - \nRange of Coping/D \n 2.83 1.16 .00 4 -.80 (.25) -.11 (.49) .59 \n \nNEO Personality Traits \n(t1)        \nNeuroticism \n 1.50 .56 .17 3.42 .26 (.23) .74 (.46) .69 \nExtraversion \n 2.15 .56 .67 3.67 .29 (.23) .05 (.46) .71 \nOpenness to Experience \n 2.46 .58 1.11 4.00 .07 (.23) .34 (.46) .60 \n           (Table continued) \n                                                                                                                                              Appendices 270 \nTable B1 (continued) \n  \nMean  \nSD  \nMin   \nMax  \nSkew (SE)  \nKurt (SE)  \n\u03b1 \n \nMajor Predictors        \nNeuroticism/S \n 1.26 .76 .00 3.50 .79 (.23) .52 (.46) .74 \nExtraversion/S \n 1.91 .69 .00 3.71 .39 (.23) .30 (.46) .69 \n \nSituation-Specific \nOutcomes        \n \nPositive Affect        \n \nAdmission         (t1)  \n1.88  \n.58  \n1.00  \n3.30  \n.34 (.23)  \n-.47 (.46)  \n.86 \n \nSurgery              (t2)  \n1.84  \n.60  \n1.00  \n3.70  \n.615 (.24)  \n.05 (.47)  \n.88 \n \nDischarge          (t3)  \n2.18  \n.74  \n1.00  \n4.00  \n.40 (.24)  \n-.55 (.48)  \n.92 \n \n6 Weeks Post     (t4)  \n2.29  \n.67  \n1.00  \n3.91  \n.06 (.25)  \n-.26 (.49)  \n.91 \n \nNegative Affect        \n \nAdmission         (t1)  \n1.34  \n.29  \n1.00  \n2.70  \n1.43 (.23)  \n3.61 (.46)  \n.72 \n \nSurgery              (t2)  \n1.35  \n.33  \n1.00  \n2.40  \n1.18 (.24)  \n1.18 (.47)  \n.82 \n \nDischarge          (t3)  \n1.15  \n.17  \n1.00  \n1.78  \n1.34 (.24)  \n1.86 (.48)  \n.50 \n \n6 Weeks Post     (t4)  \n1.21  \n.25  \n1.00  \n2.40  \n1.80 (.25)  \n4.83 (.49)  \n.70 \n \nPANAS Facets        \n \nPA-Joviality \nAdmission         (t1)  \n \n1.36  \n \n.53  \n \n1.00  \n \n3.67  \n \n1.93 (.23)  \n \n4.10 (.46)  \n \n.79 \n \nSurgery              (t2)  \n1.33  \n.48  \n1.00  \n3.00  \n1.67 (.24)  \n2.63 (.47)  \n.73 \n \nDischarge          (t3)  \n2.07  \n.82  \n1.00  \n4.00  \n.58 (.24)  \n-.47 (.48)  \n.76 \n \n6 Weeks Post     (t4)  \n1.95  \n.76  \n1.00  \n4.00  \n.76 (.25)  \n.34 (.49)  \n.83 \n \nPA-Self Assurance \nAdmission         (t1)  \n \n1.76  \n \n.63  \n \n1.00  \n \n3.67  \n \n.56 (.23)  \n \n-.26 (.46)  \n \n.50 \n \nSurgery              (t2)  \n1.79  \n.65  \n1.00  \n4.00  \n.72 (.24)  \n.47 (.47)  \n.60 \n \nDischarge          (t3)  \n1.86  \n.78  \n1.00  \n4.00  \n.80 (.24)  \n-.02 (.48)  \n.76 \n \n6 Weeks Post     (t4) \n \n  \n2.06  \n.73  \n1.00  \n4.00  \n.24 (.25)  \n-.60 (.49)  \n.73 \n           (Table continued) \n \n Appendi ces 271 \nTable B1 (continued) \n  \nMean  \nSD  \nMin   \nMax  \nSkew (SE)  \nKurt (SE)  \n\u03b1 \nSituation-Specific \nOutcomes        \n \nPA-Attentiveness \nAdmission         (t1)  \n \n2.68  \n \n.92  \n \n1.00  \n \n4.00  \n \n-.33 (.23)  \n \n-.79 (.46)  \n \n.74 \n \nSurgery              (t2)  \n2.48  \n.90  \n1.00  \n4.00  \n.03 (.24)  \n-.77 (.47)  \n.80 \n \nDischarge          (t3)  \n2.50  \n.91  \n1.00  \n4.00  \n-.04 (.24)  \n-.81 (.48)  \n.80 \n \n6 Weeks Post     (t4)  \n2.73  \n.84  \n1.00  \n4.00  \n-.59 (.25)  \n-.20 (.49)  \n.74 \n \nPA-Low Fatigue \nAdmission         (t1)  \n \n2.02  \n \n.84  \n \n1.00  \n \n4.00  \n \n.50 (.23)  \n \n-.59 (.46)  \n \n.78 \n \nSurgery              (t2)  \n2.03  \n.92  \n1.00  \n4.00  \n.47 (.24)  \n-1.00 (.47)  \n.86 \n \nDischarge          (t3)  \n2.49  \n.89  \n1.00  \n4.00  \n.04 (.24)  \n-.75 (.48)  \n.79 \n \n6 Weeks Post     (t4)  \n2.70  \n.80  \n1.00  \n4.00  \n-.40 (.25)  \n-.43 (.49)  \n.73 \n \nNA-Anxiety \nAdmission         (t1)  \n \n1.49  \n \n.46  \n \n1.00  \n \n4.00 \n  \n \n1.8 (.23)  \n \n6.78 (.46)  \n \n.69 \n \nSurgery              (t2)  \n1.54  \n.54  \n1.00  \n3.25  \n1.16 (.24)  \n1.16 (.47)  \n.78 \n \nDischarge          (t3)  \n1.19  \n.27  \n1.00  \n2.25  \n1.62 (.24)  \n2.41 (.48)  \n.53 \n \n6 Weeks Post     (t4)  \n1.31  \n.38  \n1.00  \n2.50  \n1.27 (.25)  \n1.03 (.49)  \n.61 \n \nNA-Sadness \nAdmission         (t1)  \n \n1.28  \n \n.51  \n \n1.00  \n \n3.00  \n \n1.8 (.23)  \n \n2.58 (.46)  \n \n- \n \nSurgery              (t2)  \n1.20  \n.42  \n1.00  \n3.00  \n1.91 (.24)  \n2.79 (.47)  \n- \n \nDischarge          (t3)  \n1.09  \n.29  \n1.00  \n2.00  \n2.93 (.24)  \n6.70 (.48)  \n- \n \n6 Weeks Post     (t4)  \n1.28  \n.59  \n1.00  \n4.00  \n2.66 (.25)  \n8.35 (.49)  \n- \n \nNA-Anger \nAdmission         (t1)  \n \n1.37  \n \n.33  \n \n1.00  \n \n2.33  \n \n.77 (.23)  \n \n.10 (.46)  \n \n.24 \n \nSurgery              (t2)  \n1.38  \n.36  \n1.00  \n2.33  \n.79 (.24)  \n-.06 (.47)  \n.33 \n \nDischarge          (t3)  \n1.22  \n.30  \n1.00  \n2.33  \n1.71 (.24)  \n3.15 (.48)  \n.15 \n \n6 Weeks Post     (t4)  \n1.18  \n.30  \n1.00  \n2.33  \n1.97 (.25)  \n3.10 (.49)  \n.28 \n \nNA-Guilt \nAdmission         (t1)  \n \n1.04  \n \n.21  \n \n1.00  \n \n2.52  \n \n5.53 (.23)  \n \n32.15 (.46)  \n \n.20 \n \nSurgery              (t2)  \n1.02  \n.10  \n1.00  \n1.50  \n4.81 (.24)  \n21.59 (.47)  \n- \n           (Table continued)                                                                                                                                              Appendices 272 \nTable B1 (continued) \n  \nMean  \nSD  \nMin   \nMax  \nSkew (SE)  \nKurt (SE)  \n\u03b1 \n \nSituation-Specific \nOutcomes        \nNA-Guilt \nDischarge          (t3)  \n1.01  \n.05  \n1.00  \n1.50  \n10.04 (.24)  \n100.8 (.48)  \n- \n \n6 Weeks Post     (t4) \n  \n1.02  \n.15 \n  \n1.00  \n2.00  \n6.74 (.25) \n  \n44.39 (.49)  \n.50 \n \nAffect Balance \nAdmission         (t1)  \n \n.53  \n \n.65  \n \n-1.00  \n \n2.10  \n \n.11 (.23)  \n \n-.18 (.46)  \n \n- \n \nSurgery              (t2)  \n.48  \n.74  \n-1.40  \n2.40  \n.12 (.24)  \n-.19 (.47)  \n- \n \nDischarge          (t3)  \n1.03  \n.77  \n-.30  \n3.00  \n.40 (.24)  \n-.37 (.48)  \n- \n \n6 Weeks Post     (t4) \n  \n1.08 \n  \n.74  \n-.50  \n2.80  \n-.15 (.25) \n  \n-.37 (.49) \n  \n- \n \nSatisfaction with Pre-\nSurgical Coping (t4) \n  \n3.63  \n.57  \n2  \n4  \n-1.36 (.25)  \n.73 (.49)  \n.79 \n \nLonger-Term  \nWell-Being Outcomes         \n \nLife Satisfaction (t1)  \n2.90  \n.81  \n1  \n4  \n-.54 (.23)  \n.07 (.46)  \n- \n \nLife Satisfaction (t2) \n  \n3.15  \n.73  \n1  \n4  \n-.41 (.25)  \n-.47 (.49)  \n- \n \nDepressive Symptoms (t4) \n  \n11.81  \n7.31  \n.00  \n36  \n.84 (.25)  \n.73 (.49)  \n.82 \n \nLonger-Term Functional \nOutcomes        \nNumber of Activities (t1) \n 8.49 2.04 2 11 -.49 (.23) -.13 (.46) .71 \nNumber of Activities (t4) \n 8.37 2.00 4 11 -.49 (.25) -.43 (.50) .73 \nNumber of Activities (t1; w/out Driving) \n 7.59 1.51 1.00 9.00 -1.37 (.23) 2.68 (.46) .63 \nNumber of Activities (t4; \nw/out Driving) \n 7.62 1.43 4.00 9.00 -1.09 (.25) .50 (.50) .69 \nIntensity of Limitations (t1) \n 1.73 .90 .00 3.67 -.03 (.23) -.52 (.46) .94 \nIntensity of Limitations \n(t4) \n 1.16 .82 .00 4.00 1.33 (.25) 2.89 (.50) .96 \n           (Table continued) Appendi ces 273 \nTable B1 (continued) \n  \nMean  \nSD  \nMin   \nMax  \nSkew (SE)  \nKurt (SE)  \n\u03b1 \nLonger-Term Functional \nOutcomes        \n \nIntensity of Limitations \n(t1; w/out Driving) \n  \n1.66  \n.89  \n.00  \n3.67  \n.03 (.24)  \n-.59 (.47)  \n.95 \nIntensity of Limitations \n(t4; w/out Driving) \n 1.16 .88 .00 4.00 1.20 (.26) 2.07 (.52) .96 \nNote.  Dashes indicate that due to the nature of th e scale (e.g., one item scale) the computation of \nCronbach's \u03b1 was not possible.                                                                                                                                              Appendices 274 \n8.3. Appendix C:  Documentation of Analyses \n8.3.1. The Brief COPE: Inter-Item and Int er-Scale Correlations of the Original \nTwo-Item Subscales \n \nTable C1 \nInter-Item and Inter-Scale Correlations of the Brief COPE (Situation-Specific)  \n \nBrief COPE (Situation-Specific)  \n \n1  \n \n2  \n \n3  \n \n4  \n \n5  \n \n6  \n \n7  \n \n8  \n \n9  \n \n10  \n \n11  \n \n12  \n \n13  \n \n14 \n1. Self Distraction \n .56 .33 .41 -.19 .12 -.03 .37 .11 .29 .23 .39 .12 .27 .28 \n2. Denial \n  .20 .22 -.01 -.02 -.04 .19 .14 .36 .32 .23 .00 .43 .13 \n3. Emotional Support \n   .60 -.12 .26 -.06 .16 .05 .35 .18 .20 .10 .06 .27 \n4. Behavioral Disengagement \n    -.39 -.16 -.11 -.36 -.11 -.26 -.16 -.32 -.17 -.04 -.04 \n5. Positive Reframing \n     .45 .31 .14 -.05 .10 .22 .20 .42 .18 .13 \n6. Humor \n      .24 .05 -.01 .03 .20 .07 .34 .15 -.00 \n7. Active Coping \n       .43 .06 .38 .26 .60 -.01 .31 .13 \n8. Substance Use \n        .57 .13 .13 .10 .03 .10 -.08 \n9. Instrumental Support \n         .64 .36 .30 .16 .19 .23 \n10. Venting \n          .27 .28 .16 .21 .22 \n11. Planning \n           .40 .09 .32 .15 \n12. Acceptance \n            .47 .10 .21 \n13. Self-Blame \n             .41 .20 \n14. Religion \n              .69 \nNote.  N = 110. With this sample size, all correlations greater than .19 are significant at the .05 level. \nDiagonal, bold: Item-intercorrelations of the two-item subscales of the Brief COPE (situation-specific). Appendi ces 275 \nTable C2 \nInter-Item and Inter-Scale Correlati ons of the Brief COPE (Dispositional) \n \nBrief COPE (Dispositional)  \n \n1  \n \n2  \n \n3  \n \n4  \n \n5  \n \n6  \n \n7  \n \n8  \n \n9  \n \n10  \n \n11  \n \n12  \n \n13  \n \n14 \n1. Self Distraction/D \n .50 .47 .17 -.12 .29 .14 .45 .02 .32 .25 .36 .08 .26 .41 \n2. Denial/D \n  .41 .06 .02 .21 .05 .29 -.08 .31 .37 .32 .07 .45 .21 \n3. Emotional Support/D \n   .52 -.19 .21 .01 .18 .08 .45 .20 .15 .14 .17 .29 \n4. Behavioral Disengagement/D \n    -.26 -.17 .11 -.49 .04 -.46 -.04 -.41 -.16 .01 -.20 \n5. Positive Reframing/D \n     .49 .38 .16 -.05 .24 .16 .07 .53 .24 .22 \n6. Humor/D \n      .37 .04 -.03 -.10 .12 -.10 .29 .07 -.01 \n7. Active Coping/D \n       .45 -.12 .50 .32 .74 .07 .25 .30 \n8. Substance Use/D \n        .52 -.06 -.00 -.01 -.07 .11 .04 \n9. Instrumental Support/D \n         .63 .22 .48 -.06 .35 .31 \n10. Venting/D \n          .12 .30 .17 .46 .30 \n11. Planning/D \n           .43 .10 .40 .31 \n12. Acceptance/D \n            .61 .06 .19 \n13. Self-Blame/D \n             .48 .34 \n14. Religion/D \n              .70 \nNote.  n = 94. With this sample size, all correlations greater than .20 are significant at the .05 level. \nDiagonal, bold: Item-inter correlations of the two-item subscales of the Brief COPE (dispositional). /D= \ndispositional. \n \n \n                                                                                                                                              Appendices 276 \n8.3.2. The Brief COPE: Documentation on the Final CFA Models of the Situation-\nSpecific and Dispositional Versions \n \nTable C3 \nFinal Modified CFA Models of the Brief COPE-S ituation-Specific and -Dispos itional with Significant \nCoefficients Presented in Completely Standardized Form \n  \nSupport Seeking  \nFocus on Positive  \nEvasive Coping  \nActive Coping \n \u0424=1 \u0424=1 \u0424=1 \u0424=1 \n Sit.-Spec. Dispo. Sit.-Spec. Dispo. Sit.-Spec. Dispo. Sit.-Spec. Dispo. \n \u03bb \n(\u03b4) \u03bb \n(\u03b4) \u03bb \n(\u03b4) \u03bb \n(\u03b4) \u03bb \n(\u03b4) \u03bb \n(\u03b4) \u03bb \n(\u03b4) \u03bb \n(\u03b4) \n \nEmotional Support  \n.46 \n(.79)  \n.51 \n(.74)       \nInstrumental Support .74 \n(.45) .83 \n(.31)       \nReligion \n .37 \n(.86) .46 \n(.79)       \nHumor   .51 \n(.74) .38 \n(.86)     \nAcceptance   .64 \n(.59) .52 \n(.75)     \nPositive Reframing \n   .66 \n(.56) 1.00 \n(.00)*  \n    \nDenial     .62 \n(.61) .61 \n(.63)   \nSelf-Blame     .55 \n(.70) .74 \n(.45)   \nVenting \n     .55 \n(.70) .61 \n(.63)   \nActive Coping       .77 \n(.41) .82 \n(.33) \nPlanning \n \n       .78 \n(.39) .91 \n(.17) \nNote.  N situation-specific  = 110. n dispositional  = 94. All coefficients are signifi cant at the .01 level and presented \nin completely standardized form. *Using Rindskopf parameterization, negative variances are not possible, \nzero unique variances, however, do occur (Rindskopf, 1983).  Appendi ces 277 \nTable C4  \nIntercorrelations of the Latent Factors of the Final Modified CFA, Brief COPE Situation-Specific (Above \nDiagonal) and Dispositional  (Below Diagonal) \n \nBrief COPE  \n1  \n2  \n3  \n4 \n1. Support Seeking  .25\u2020 .71*** .55*** \n2. Focus on Positive .32**  .28\u2020 .21 \n3. Evasive Coping .55** .31*  .59*** \n4. Active Coping .65*** .11 .56***  \nNote.  94 < N < 110.  Above Diagonal: Latent factor interco rrelations, situation-specific. Below diagonal: \nLatent factor intercorrelations: Dispositional. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001.  \n \n8.3.3. The PANAS: Additional Analyses on PA and NA Subfacets \n \nTable C5 \nMeans and Contrasts of PA Facets Pre-Surgery \nPA Facet Admission Surgery \n Mean  \n(SD) Contrasts \n(Simple) Mean \n(SD) Contrasts \n(Simple) \n  F dfs \u03b72  F dfs \u03b7 2 \n \nAttentiveness 2.68 \n(.92)  \nReference 2.48 \n(.90)  \nReference \n \nJoviality 1.36 \n(.53) 256.39*** 1  \n109 .70 1.33 \n(.48) 218.45*** 1 \n101 .68 \n \nSelf-Assurance 1.76 \n(.63) 208.35*** 1 \n109 .66 1.79 \n(.65) 107.17*** 1 \n101 .51 \n \nLow-Fatigue 2.02 \n(.84) 88.51*** 1 \n109 .45 2.03 \n(.92) 43.79*** 1 \n101 .30 \nNote.  Only time-points for which predictions were ma de have been tested. Subfacets Joviality, Self \nAssurance, and Low-Fatigue are comp ared to Attentiveness as the facet of reference. Admission: WSF \nFacet Wilk's \u03bb=.29, F(3, 107)= 88.75, p<.001, partial \u03b7 2=.71. Surgery: WSF Facet Wilk's \u03bb=.32, F(3, \n99)= 71.78, p<.001, partial \u03b7 2=.69. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001.  \n \nTable C6 \nMeans and Contrasts of NA Facets Pre-Surgery \nNA Facet Admission Surgery \n Mean  \n(SD) Contrasts \n(Simple) Mean \n(SD) Contrasts \n(Simple) \n  F dfs \u03b7 2  F dfs \u03b7 2 \n \nAnxiety 1.49 \n(.46)  \nReference 1.54 \n(.54)  \nReference \n \nSadness 1.28 \n(.51) 16.85*** 1 \n109 .13 \n 1.20 \n(.42) 51.26*** 1 \n101 .34 \n \nAnger 1.37 \n(.33) 11.34** 1 \n109 .09 1.38 \n(.36) 15.96*** 1 \n101 .14 \n \nGuilt 1.04 \n(.21) 92.13*** 1 \n109 .46 1.02 \n(.09) 94.10*** 1 \n101 .48 \nNote.  Only time-points for which predictions were made  have been tested. Subfacets Sadness, Anger, and \nGuilt are compared to Anxiety as the facet of reference. Admission: WSF Facet Wilk's \u03bb=.49, F(3, 107)= \n36.96, p<.001, partial \u03b7 2=.51. Surgery: WSF Facet Wilk's \u03bb=.47, F(3,99)= 37.02, p<.001, partial \u03b7 2=.53. \u2020  \np < .10, * p < .05, ** p < .01, *** p < .001.                                                                                                                                               Appendices 278 \n8.3.4. Additional Control Analyses for the Prediction of State Positive Affect \n \nTable C7 \nSummary of Regression Analyses:  NEO-Personality Traits Predicting State Positive Affect \n \n \nOutcome \n  \nR  \nR2  \n\u2206R2 \nPositive Affect t1    \nMorbidity \nPre-Visual Acuity S \nAnesthesia  \n.40  \n.16***  \nNEO added .50 .25 .09* \n \nPositive Affect t2    \nMorbidity \nAnesthesia .18 .03  \nNEO added .37 .13 .10* \n \nPositive Affect t3    \nMorbidity .08 .01  \nNEO added .33 .11 .10* \n \nChange PA t2    \nPA t1 and \nMorbidity \nPre-Visual Acuity S \nAnesthesia  \n \n.72  \n \n.51***  \nNEO added .74 .54 .03 \n \nChange PA t3    \nPA2 and  \nMorbidity \nPre-Visual Acuity S \nAnesthesia  \n \n.74  \n \n.55***  \nNEO added .77 .59 .04* \nNote.  PA = Positive Affect. NEO = Neuroticism, Extraversion, Openness. Pre-Visual Acuity S = pre-\nsurgical visual acuity in the eye operated on.\u2020  p < .10, * p < .05, ** p < .01, *** p < .001.  \n \nTable C8 \nSummary of Regression Analyses Situation-Specific Coping Predicting State Positive Affect  \n \nOutcome \n  \nR  \nR2  \n\u2206R2 \nPositive Affect t1    \nMorbidity \nPre-Visual Acuity S \nAnesthesia  .40 .16***  \nCoping added .58 .33 .17*** \n \nPositive Affect t2    \nMorbidity \nAnesthesia .18 .03  \nCoping added .48 .23 .20*** \n(Table continued) Appendi ces 279 \nTable C8 (continued) \n \nOutcome \n  \nR  \nR2  \n\u2206R2 \n \nPositive Affect t3    \nMorbidity .08 .01  \nCoping added \n .44 .19 .18*** \n \nPositive Affect t4    \nMorbidity \nPost-Visual Acuity S  \n.20  \n.04  \nCoping added \n .35 .12 .08 \n \nChange PA t2    \n \nPA t1 and \nMorbidity \nPre-Visual Acuity S \nAnesthesia  \n \n.72  \n \n.51***  \nCoping added \n .74 .54 .03 \n \nChange PA t3    \n \nPA t2 and  \nMorbidity \nPre-Visual Acuity S \nAnesthesia  \n \n.74  \n \n.55***  \nCoping added \n .76 .57 .02 \nNote.  PA = Positive Affect. Coping = situation specific coping strategies: Focus on Positive, Active \nCoping, Support Seeking, Evasive Coping. Pre-/Post Visual Acuity S = pre-/post-surgical visual acuity in \nthe eye operated on. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001.                                                                                                                                               Appendices 280 \n8.3.5. Additional Control Analyses for the Prediction of Coping by Higher-Order \nPersonality Traits  \n \nTable C9 \nSummary of Hierarchical Regression Analyses: NEO-Personality Traits Predicting Situation-Specific \nCoping \n \nCoping  \nSituation-Specific \n(N = 110)  \nFocus on Positivea  \nActive Copingb  \nSeeking Supportc  \nEvasive Copingd \n \u03b2 \u2206R2 \u03b2 \u2206R2 \u03b2 \u2206R2 \u03b2 \u2206R2 \n \nRival Predictors   \n.09*   \n.23***   \n.26***   \n.24*** \n \nNeuroticism \n  \n-.21*  \n.04*  \n-.03  \n.00  \n.17\u2020  \n.02\u2020  \n.18*  \n.03* \n \nRival Predictors   \n.09*   \n.23***   \n.26***   \n.24*** \n \nExtraversion \n  \n.22*  \n.05*  \n-.01  \n.00  \n.11  \n.01  \n-.04  \n.00 \n \nRival Predictors   \n.09*   \n.23***   \n.26***   \n.24*** \n \nOpenness \n  \n.13  \n.01  \n.24**  \n.05**  \n.03  \n.00  \n-.21*  \n.04* \nNote.  a: Rival predictors of Focus on Positive coping: previous experience with cataract surgery. b: Rival \npredictors of Active Coping: type of anesthesia, best  corrected visual acuity in  the eye operated on. c: \nRival predictors of Seeking S upport: Multimorbidity. d: Rival pred ictors of Evasive Coping: none. \u2020  p < \n.10, * p  < .05, ** p < .01, *** p < .001.  \n \n \nTable C10 \nSummary of Hierarchical Regre ssion Analyses: NEO-Personality Tra its Predicting Dispositional Coping  \n \nCoping Dispositional  \n(n = 94)  \nFocus on \nPositive/Db  \nActive  \nCoping/Da  \nSeeking \nSupport/Da  \nEvasive Coping/D\na \n \u03b2 \u2206R2 \u03b2 \u2206R2 \u03b2 \u2206R2 \u03b2 \u2206R2 \n \nRival Predictors  \n  \n.10   \n.31***   \n.34***   \n.28*** \n \nNeuroticism \n  \n-.00  \n.00  \n.02  \n.00  \n.07  \n.00  \n.27**  \n.06** \n \nRival Predictors   \n.10   \n.31***   \n.34***   \n.28*** \n \nOpenness \n  \n.11  \n.01  \n.26**  \n.07**  \n-.08  \n.01  \n-.17\u2020  \n.03\u2020 \nNote.  a: Rival predictors: Age, sex. b: Rival predictors: Age, sex, 1st/2nd Eye. \u2020  p < .10, * p < .05, ** p < \n.01, *** p  < .001.  \n \n \n Appendi ces 281 \n8.3.6. Additional Documentation of Analys es Concerning Coping Satisfaction \n \nTable C11 \nSummary of Hierarchical Regression Analysis for Neuroticism Predicting Coping Satisfaction \n \nCoping Satisfaction  \nB \n  \nSE B  \n\u03b2 \nStep1    \nAge .01 .01 .22* \nSex -.12 .12 -.11 \n1st/2nd Eye .18 .12 .16 \nStep 2    \nAge .02 .01 .27* \nSex -.06 .12 -.05 \n1st/2nd Eye .15 .11 .14 \nNeuroticism -.27 .10 -.28** \nNote.  R2 = .08\u2020 for Step 1; \u2206R2  = .07** for Step 2. \u2020  p < .10, * p < .05, ** p < .01, *** p <.001.  \n \n \nTable C12 \nSummary of Hierarchical Regression Analysis for Situation-Specific Coping Predicting Coping \nSatisfaction  \n \nCoping Satisfaction  \nB \n  \nSE B  \n\u03b2 \nStep1    \nAge .01 .01 .22* \nSex -.12 .12 -.11 \n1st/2nd Eye .18 .12 .16 \nStep 2    \nAge .02 .01 .19\u2020 \nSex -.15 .12 -.13 \n1st/2nd Eye .09 .11 .08 \nFocus on Positive .29 .11 .29** \nSupport Seeking .05 .11 .06 \nActive Coping -.24 .09 -.27* \nEvasive Coping -.34 .19 -.20\u2020 \nNote . R2 = .08\u2020 for Step 1; \u2206R2  = .17** for Step 2. \u2020  p < .10, * p < .05, ** p < .01, *** p <.001. \n                                                                                                                                              Appendices 282 \n8.3.7. Content-Free Aspects of Coping Predict Affect Balance \n \nTable C13 \nSummary of Hierarchical Regression Analysis: Situation-Specific Content-Free Aspects of Coping \nPredicting Affect Balance.  \n \nOutcome \n  \n\u03b2  \nR  \n\u2206R2 \n \nAffect Balance t1 (N=110)    \nRival Predictors a  - .45 .20** \nadd Total Range of Coping .13 .47 .01 \nadd Selective Coping .28** .54 .08** \n \nAffect Balance t2 (n=102)    \nRival Predictors b - .43 .18** \nadd Total Range of Coping .12 .44 .01 \nadd Selective Coping .23* .50 .05* \n \nAffect Balance t3 (n=101)    \nRival Predictors c - .32 .10* \nadd Total Range of Coping .11 .34 .01 \nadd Selective Coping .30** .45 .09** \n \nAffect Balance t4 (n=94)    \nRival Predictors d - .32 .10\u2020 \nadd Total Range of Coping .18\u2020 .36 .03\u2020 \nadd Selective Coping -.01 .36 .00 \n \nChange in Affect Balance t2 to t3    \nRival Predictors c \n(Affect Balance t2 added) - .71 .50*** \nadd Total Range of Coping .02 .71 .00 \nadd Selective Coping .15\u2020 .72 .02\u2020 \n \nChange in Affect Balance t3 to t4    \nRival Predictors d \n(Affect Balance t3 added) - .39 .15* \nadd Total Range of Coping .19\u2020 .44 .04\u2020 \nadd Selective Coping -.09 .45 .01 \nNote.  \u2020  p < .10, * p < .05, ** p < .01, *** p < .001. a: Age, sex, 1st/2nd Eye, multimorbidity, type of \nanesthesia, pre-visual acuity in the eye operated on. b: Age, sex, 1st/2nd Eye, anesthesia. c: Age, sex, 1st/2nd \nEye. d: Age, sex, 1st/2nd Eye, change in visual acuity in the eye operated on, multimorbidity. \n \nTable C14 \nSummary of Hierarchical Regre ssion Analysis: Situation-Specific Content-Free Aspects of Coping and \nCoping Content Scales Predicting Affect Balance.  \n \nOutcome \n  \n\u03b2  \nR  \n\u2206R2 \n \nAffect Balance t1 (n = 109)    \nSit.-Spec. Coping Scales - .45 .20*** \nadd Total Range of Coping .12 .45 .00 \nadd Selective Coping .05 .45 .00 \n              (Table continued) Appendi ces 283 \nTable C14 (continued) \n \nOutcome \n  \n\u03b2  \nR  \n\u2206R2 \n \nAffect Balance t2 (n = 101)    \nSit.-Spec. Coping Scales - .43 .19*** \nadd Total Range of Coping .12 .44 .01 \nadd Selective Coping -.09 .44 .00 \n \nAffect Balance t3 (n = 100)    \nSit.-Spec. Coping Scales - .40 .16** \nadd Total Range of Coping .14 .41 .00 \nadd Selective Coping .14 .42 .01 \n \nAffect Balance t4 (n = 93)    \nSit.-Spec. Coping Scales - .34 .11* \nadd Total Range of Coping .28* .40 .05* \nadd Selective Coping -.25 .43 .02 \n \nChange in Affect Balance t2 to t3 \n(n = 100)    \nSit.-Spec. Coping Scales \n(Affect Balance t2 added) - .72 .51*** \nadd Total Range of Coping .04 .72 .00 \nadd Selective Coping .20 .73 .01 \n \nChange in Affect Balance t3 to t4 \n(n = 85)    \nSit.-Spec. Coping Scales \n(Affect Balance t3 added) - .43 .19*** \nadd Total Range of Coping .31 .50 .06* \nadd Selective Coping .26 .52 .02 \nNote.  \u2020  p < .10, * p < .05, ** p < .01, *** p < .001. Situation-specific coping scales: Focus on Positive, \nActive Coping, Support Seeking, Evasive Coping. \n \n8.3.8. Content-Free Aspects of Coping Predicting Affect Above and Beyond \nContent Scales? \n \nTable C15  \nSummary of Hierarchical Regre ssion Analyses: Conten t and Content-Free Coping Predicting Positive \nAffect at Different Points in Time. \n \nOutcome \n  \n\u03b2  \nR  \n\u2206R2 \n \nPositive Affect t1 (n = 109)  \n   \nSit.-Spec. Coping Scales - .45 .21*** \nadd Total Range of Coping  .25 .46 .01 \nadd Selective Coping .15 .47 .01 \n \nPositive Affect t2 (n = 102)    \nSit.-Spec. Coping Scales - .44 .19** \nadd Total Range of Coping .38* .49 .05* \nadd Selective Coping -.04 .49 .00 \n                            (Table continued)                                                                                                                                              Appendices 284 \nTable C15 (continued) \n \nOutcome \n  \n\u03b2  \nR  \n\u2206R2 \n \nPositive Affect t3 (n = 101)    \nSit.-Spec. Coping Scales - .42 .18** \nadd Total Range of Coping .24 .43 .01 \nadd Selective Coping .15 .44 .01 \n \nPositive Affect t4 (n = 94)    \nSit.-Spec. Coping Scales - .30 .09\u2020 \nadd Total Range of Coping .40* .41 .07** \nadd Selective Coping -.18 .42 .01 \n \nChange in Positive Affect t2 to t3 \n(n = 100)    \nSit.-Spec. Coping Scales  (PA t2 \nadded)  - .75 .57*** \nadd Total Range of Coping -.04 .76 .00 \nadd Selective Coping .18 .76 .01 \n \nChange in Positive Affect t3 to t4 \n(n = 85)    \nSit.-Spec. Coping Scales (PA t3 added)  - .47 .22*** \nadd Total Range of Coping .43* .55 .08** \nadd Selective Coping -.20 .56 .01 \nNote.  PA= Positive Affect. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001. Situation-specific coping scales: \nFocus on Positive, Active Coping, Support Seeking, Evasive Coping. \n \nTable C16  \nSummary of Hierarchical Regression Analyses: Content and Content-Free Coping Predicting Negative \nAffect at Different Points in Time. \n \nOutcome \n  \n\u03b2  \nR  \n\u2206R2 \n \nNegative Affect t1 (n = 109)  \n   \nSit.-Spec. Coping Scales - .49 .24*** \nadd Total Range of Coping .24 .50 .01 \nadd Selective Coping .20 .51 .02 \n \nNegative Affect t2 (n = 101)    \nSit.-Spec. Coping Scales - .36 .13* \nadd Total Range of Coping .41* .41 .04* \nadd Selective Coping .12 .41 .01 \n \nNegative Affect t3 (n = 100)    \nSit.-Spec. Coping Scales - .28 .08 \nadd Total Range of Coping .44* .36 .06* \nadd Selective Coping .01 .36 .00 \n \nNegative Affect t4 (n = 93)    \nSit.-Spec. Coping Scales - .35 .13* \nadd Total Range of Coping .26 .36 .01 \nadd Selective Coping .28 .39 .02 \n                            (Table continued) Appendi ces 285 \nTable C16 (continued) \n \nOutcome \n  \n\u03b2  \nR  \n\u2206R2 \n \nChange in Negative Affect t2 to t3 \n(n = 100)    \nSit.-Spec. Coping Scales (NA t2 \nadded) - .51 .26*** \nadd Total Range of Coping .28 .53 .03\u2020 \nadd Selective Coping -.04 .53 .00 \n \nChange in Negative Affect t3 to t4 \n(n = 85)    \nSit.-Spec. Coping Scales (NA t3 added) - .37 .14* \nadd Total Range of Coping .28 .39 .01 \nadd Selective Coping .27 .41 .02 \nNote.  NA= Negative Affect. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001. Situation-specific coping \nscales: Focus on Positive, Active Copi ng, Support Seeking, Evasive Coping. \n \n8.3.9. Content-Free Aspects of Coping Predicting Long-Term Outcomes Above \nand Beyond Content Scales? \n \nTable C17  \nSummary of Hierarchical Regression Analyses: Dispositional Content and Content-Free Measures of \nCoping Predicting Life Satisfaction (t1). \nLife Satisfaction t1 \u03b2 R \u2206R2 \n \nRival Predictors a  \n-  \n.33  \n.11* \n \nDispositional Coping Scales b   \n.51  \n.26*** \nadd Total Range of Coping/D -.11 .51 .00 \nNote.  \u2020  p < .10, * p < .05, ** p < .01, *** p < .001. a: Age, sex, mutlimorbid ity, pre-surgical visual acuity \nin the eye operated on. b: Dispositional scales : Focus on Positive/D, Seeking Support/D, Active \nCoping/D, Evasive Coping/D.                                                                                                                                              Appendices 286 \n8.3.10. Age and Multimorbidity \n \n \nAge (Years) 90 80 70 60 50 40 Numb er of Unw eighted M edica l Diagnoses 10 \n8 \n6 \n4 \n2 \n0 \n-2 r = .13, n.s. \nFigure C 1. Age t rajectory: N umber of  unw eighted medi cal diagnoses, N =110.  \n \n \nTable C18 \nSpearman Correla tions of Differen t Disea ses with  Age. \nDiagnoses \nGerman  \nEnglish  \nAge \nArthritis o der Rheuma Arthritis  \n .22* \nErkrankungen der Leber, des M agen- oder \nDarm trakts Gastrointestinal Diseases  -.02 \n \nHerzerkrankungen Heart Disease \n .10 \nNieren- oder Harnwegserkrankungen  Kidney and Uri nary Di seases \n .14 \nKreislaufst \u00f6rungen Blood Pressure Irregularities \n .20\u2020 \nStoffwechsel erkrankungen (z.B . Schi lddr\u00fcsen oder \nHorm onerkrnakungen) Metabolic Diseases \n -.02 \nDiabetes Diabetes \n -.00 \nOsteoporose Osteoporosi s \n .31** \nParki nson Parkinson' s Disease \n .13 \nL\u00e4hm ungen i nfolge eines Schl aganfal ls Partial Paralyses after Stroke \n -.00 \nH\u00fcftleid en Hip-Rel ated Probl ems \n -.11 \nNote. Spearm an Correlations. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001. Appendi ces 287 \n8.4. Appendix D: Net of Affectiv ity Versions Neuroticism/S and \nExtraversion/S Additional Analyses \n \n8.4.1. Neuroticism/S and Extraversion/S Predict Positive Affect  \n \nTable D1  \nPearson Correlations between Personality Traits and Outcome Variables St ate Positive and Negative \nAffect. \n  \nNeuroticism/S  \nExtraversion/S \nPA t1 (N = 110) -.16 .13 \nPA t2 (n = 102) -.17\u2020 .27** \nPA t3 (n = 101) -.31** .22* \nPA t4 (n = 94) -.17 .10 \n \nNA t1 (N = 110)  \n.37***  \n.01 \nNA t2 (n = 102) .30** -.04 \nNA t3 (n = 101) .22** -.02 \nNA t4 (n = 94) .09 .12 \nNote.  PA= Positive Affect; NA= Negative Affect. Neuroticism/S=net of negative affectivity items; \nExtraversion/S=net of Positive Affectivity items. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001. \n \n \nTable D2 \nHierarchical Regression Analysis: NEO/S Personality Traits Predicting Positive Affect t1  \nPositive Affect t1 (N = 110) B SE B \u03b2 \nStep1    \nAge -.01 .01 -.14 \nSex -.22 .11 -.19\u2020 \n1st /2nd Eye .20 .11 .18\u2020 \nStep 2    \nAge -.01 .01 -.09 \nSex -.20 .11 -.18\u2020 \n1st/2nd Eye .15 .11 .13 \nNeuroticism/S -.03 .08 -.04 \nExtraversion/S .05 .08 .06 \nOpenness .23 .09 .23* \nNote.  R2 = .09*  for Step 1; \u2206R2  = .06\u2020  for Step 2. \u2020  p < .10, * p < .05, ** p < .01, *** p<.001.    \n \nTable D3 \nHierarchical Regression Analysis: NEO/S Personality Traits Predicting Positive Affect t2  \n \nPositive Affect t2 (n = 102)   \nB  \nSE B  \n\u03b2 \nStep1    \nAge -.01 .01 -.15 \nSex -.21 .12 -.17\u2020 \n1st/2nd Eye .28 .11 .23* \nStep 2    \nAge -.01 .01 -.10 \nSex -.18 .12 -.15 \n1st/2nd Eye .23 .11 .20* \nNeuroticism/S -.04 .08 -.05 \nExtraversion/S .18 .08 .21* \nOpenness .11 .10 .11 \nNote. R2 = .11** for Step 1; \u2206R2  = .06\u2020  for Step 2. \u2020  p < .10, * p < .05, ** p < .01, *** p  <.001.                                                                                                                                              Appendices 288 \nTable D4 \nHierarchical Regression Analysis: NEO/S Personality Traits Predicting Positive Affect t3  \nPositive Affect t3 (n = 101) B SE B \u03b2 \nStep1    \nAge -.01 .01 -.08 \nSex -.30 .15 -.20* \n1st/2nd Eye .28 .14 .19\u2020 \nStep 2    \nAge -.00 .01 -.02 \nSex -.18 .16 -.12 \n1st/2nd Eye .26 .14 .18\u2020 \nNeuroticism/S -.23 .11 -.23* \nExtraversion/S .15 .11 .14 \nOpenness .01 .12 .01 \nNote. R2 = .09* for Step 1; \u2206R2  = .08* for Step 2. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001 .   \n \nTable D5 \nHierarchical Regression Analysis : NEO/S Personality Traits Predicting Change in PA t1 to t2  \nPositive Affect t2 (n = 102) B SE B \u03b2 \nStep1    \nPositive Affect t1 .68 .08 .67*** \nAge -.00 .01 -.04 \nSex -.07 .09 -.06 \n1st/2nd Eye .12 .09 .09 \nStep 2    \nPositive Affect t1 .68 .08 .67*** \nAge -.00 .01 -.02 \nSex -.06 .09 -.06 \n1st/2nd Eye .11 .09 .10 \nNeuroticism/S .03 .06 .00 \nExtraversion/S .14 .06 .17* \nOpenness -.05 .08 -.05 \nNote. R2 = .52*** for Step 1; \u2206R2  = .03  for Step 2. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001 .   \n \nTable D6 \nHierarchical Regression Analys is: NEO/S Personality Traits Predicting Change in PA t2 to t3  \nPositive Affect t3 (n = 101) B SE B \u03b2 \nStep1    \nPositive Affect t2 .90 .09 .73*** \nAge .00 .01 .03 \nSex -.11 .11 -.08 \n1st/2nd Eye .03 .10 .02 \nStep 2    \nPositive Affect t2 .90 .09 .72 \nAge .00 .01 .05 \nSex -.01 .11 -.01 \n1st/2nd Eye .05 .10 .03 \nNeuroticism/S -.20 .08 -.20** \nExtraversion/S -.01 .08 -.01 \nOpenness -.09 .09 -.07 \nNote. R  = .55***  for Step 1; \u2206R= .04*  for Step 2. p < .10, * p < .05, ** p < .01, *** p < .001.  2 2  \u2020  \n \n \n Appendi ces 289 \n8.4.2. Neuroticism/S Predicts Negative Affect  \n \nTable D7 \nSummary of Hierarchical Regression Analysis: Neuroticism/S Predicting Negative Affect t1  \nNegative Affect t1 (N = 110 ) B SE B \u03b2 \nStep1    \nAge -.01 .00 -.14 \nSex .11 .06 .20* \n1st/2nd Eye -.06 .06 -.10 \nStep 2    \nAge -.01 .00 -.20* \nSex .05 .06 .08 \n1st/2nd Eye -.05 .05 -.08 \nNeuroticism/S .14 .04 .38*** \nNote. R2 = .06\u2020  for Step 1; \u2206R2  = .13***  for Step 2. \u2020  p < .10, * p < .05, ** p < .01, ***  p < .001 .   \n \nTable D8 \nSummary of Hierarchical Regression Analysis: Neuroticism/S Predicting Negative Affect t2  \nNegative Affect t2 (n = 102) B SE B \u03b2 \nStep1    \nAge -.00 .00 -.06 \nSex .18 .07 .27** \n1st/2nd Eye -.16 .06 -.25** \nStep 2    \nAge -.00 .00 -.10 \nSex .12 .07 .19\u2020 \n1st/2nd Eye -.17 .06 -.25** \nNeuroticism/S .12 .04 .27** \nNote. R2 = .13** for Step 1; \u2206R2  = .06** for Step 2. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001.   \n \nTable D9 \nSummary of Hierarchical Regression Analysis: Neuroticism/S Predicting Negative Affect t3  \nNegative Affect t3 (n = 101) B SE B \u03b2 \nStep1    \nAge .00 .00 .04 \nSex .04 .04 .12 \n1st/2nd Eye -.03 .03 -.09 \nStep 2    \nAge .00 .00 .01 \nSex .02 .04 .05 \n1st/2nd Eye -.03 .03 -.09 \nNeuroticism/S .05 .03 .20\u2020 \nNote. R2 = .03 for Step 1; \u2206R2  = .03\u2020 for Step 2. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001.                                                                                                                                                Appendices 290 \n8.4.3. Neuroticism/S and Extraversion/S Predict Long-Term Outcomes \n \nTable D10 \nSummary of Hierarchical Regression Analysis: Ne uroticism/S and Extraversion/S Predicting Depressive \nSymptoms and Life Satisfaction \n \nOutcome \n  \n\u03b2 (last step)  \nR2  \n\u2206R2 \nDepressive Symptoms    \nRival Predictors a  .34***  \nNeuroticism/S \nadded \n .38*** .46 .11*** \nLife Satisfaction t4    \nRival  Predictors b  .08\u2020  \nExtraversion/S \nadded \n .16 .11 .03 \nChange in Life \nSatisfaction t1 to t4    \nRival  Predictors (t1 \nadded) b  .18**  \nExtraversion/S \nadded \n .22* .22 .04* \nNote.  a: Age, sex, multimorbidity, change in visual acuity in the eye operated on. b: Age, sex, \nmultimorbidity, change in visual acuity in the eye operated on. \u2020  p < .10, * p < .05, ** p < .01, *** p < \n.001.  \n \n8.4.4. Neuroticism/S and Extraversion/S Predict Coping \n \nTable D11 \nCorrelations of Neuroticism/S and Extraversion/S with Situation- Specific and Dispos itional Coping. \n \nCoping Situation-Specific (N=110)  \nNeuroticism/S  \nExtraversion/S \n \nFocus on Positive  \n-.10  \n.23* \n \nActive Coping  \n.06  \n.18\u2020 \n \nSupport Seeking  \n.28**  \n.11 \n \nEvasive Coping  \n.24*  \n.04 \n \nCoping Dispositional (n = 94)   \n \nFocus on Positive/D  \n.16  \n.01 \n \nActive Coping/D  \n.11  \n.05 \n \nSupport Seeking/D  \n.23*  \n.02 \n \nEvasive Coping/D  \n.32**  \n.07 \nNote. \u2020  p < .10, * p < .05, ** p < .01, *** p < .001.  Appendi ces 291 \nTable D12 \nSummary of Hierarchical Regression Analyses: Ne uroticism/S and Extraversion/S Predicting Situation-\nSpecific Coping. \n \nCoping  \nSituation-Specific \n(N = 110)  \nFocus on Positive  \nActive Coping  \nSeeking Support  \nEvasive Coping \n \u03b2 \u2206R2 \u03b2 \u2206R2 \u03b2 \u2206R2 \u03b2 \u2206R2 \n \nRival Predictors   \n.12*  \n  \n.23***   \n.27***   \n.25*** \n \nNeuroticism/S \n  \n-.17  \n.02  \n-.01  \n.00  \n.16\u2020  \n.02\u2020  \n.21*  \n.04* \n \nRival Predictors   \n.12*   \n.23***   \n.27***   \n.25*** \n \nExtraversion/S \n  \n.22*  \n.04*  \n.14  \n.02  \n.04  \n.00  \n-.06  \n.00 \nNote.  \u2020  p < .10, * p < .05, ** p < .01, *** p < .001. Betas are last step. Rival Predictors: Age, sex, 1./2. \neye, and all situation-specific coping scal es but the one serving as the outcome. \n \nTable D13 \nSummary of Hierarchical Regression Analyses : Neuroticism/S and Extraversion/S Predicting \nDispositional Coping. \n \nCoping \nDispositional  \n(n = 94)  \nFocus on Positive/D  \nActive Coping/D  \nSeeking Support/D  \nEvasiveCoping/D \n \u03b2 \u2206R2 \u03b2 \u2206R2 \u03b2 \u2206R2 \u03b2 \u2206R2 \n \nRival Predictors   \n.10   \n.31***   \n.34***   \n.28*** \n \nNeuroticism/S \n  \n.10  \n.01  \n.02  \n.00  \n.03  \n.00 \n  \n.26**  \n.06** \n \nRival Predictors   \n.10   \n.31***   \n.34***   \n.28*** \n \nExtraversion/S \n  \n.01  \n.00  \n-.00  \n.00  \n-.05  \n.00  \n.09  \n.01 \nNote.  \u2020  p < .10, * p < .05, ** p < .01, *** p < .001. Betas are last step. Rival Predictors: Age, sex, \nmultimorbidity, change in visual acuity and all dispositional coping scales but the one serving as the \noutcome \n \n \n \n \n \n \n \n \n \n \n \n \n                                                                                                                                              Appendices 292 \n8.4.5. Neuroticism/S and Extraversion/S Predict the Affects: Directly and \nIndirectly \n \nTable D14 \nSummary of Hierarchical Regression Analysis for Variables Predicting Negative Affect t1  \nNegative Affect t1 (N = 110) B SE B \u03b2 \nStep1    \nAge -.01 .00 -.14 \nSex .11 .06 .20* \n1st/2nd Eye -.06 .05 -.10 \nStep 2    \nAge -.01 .00 -.20* \nSex .05 .06 .08 \n1st/2nd Eye -.05 .05 -.08 \nNeuroticism/S .14 .04 .38*** \nStep 3    \nAge -.01 .00 -.17* \nSex .04 .05 .07 \n1st/2nd Eye -.04 .05 -.07 \nNeuroticism/S .10 .04 .27** \nFocus on Positive -.09 .04 -.19* \nSeeking Support .14 .05 .29** \nActive Coping .07 .04 .18\u2020 \nEvasive Coping .02 .08 .00 \nNote. R2 = .06\u2020 for Step 1; \u2206R2  = .13*** for Step 2; \u2206R2  = .14*** for Step 3 . \u2020  p < .10, * p < .05, **  \np < .01, *** p < .001 .   \n \n Table D15 \nSummary of Hierarchical Regression Analysis for Variables Predicting Negative Affect t2  \nNegative Affect t2 (n = 102) B SE B \u03b2 \nStep 1    \nAge -.00 .00 -.06 \nSex .18 .07 .27** \n1st/2nd Eye -.16 .06 -.25** \nStep 2    \nAge -.00 .00 -.10 \nSex .12 .07 .19\u2020 \n1st/2nd Eye -.17 .06 -.25** \nNeuroticism/S .12 .04 .27** \nStep 3    \nAge -.00 .00 -.10 \nSex .14 .07 .21* \n1st/2nd Eye -.16 .06 -.25** \nNeuroticism/S .06 .05 .15 \nFocus on Positive -.06 .05 -.12 \nSeeking Support .06 .06 .11 \nActive Coping .00 .05 .00 \nEvasive Coping .20 .09 .23* \nNote. R2 = .13** for Step 1; \u2206R2  = .06** for Step 2; \u2206R2  = .07\u2020 for Step 3 . \u2020  p < .10, * p < .05, **  \np < .01, *** p < .001 .   \n \n \n \n \n Appendi ces 293 \nTable D16 \nSummary of Hierarchical Regression Analysis for Variables Predicting Positive Affect t2  \nPositive Affect t2 (n = 102) B SE B \u03b2 \nStep 1    \nAge -.01 .01 -.15 \nSex -.21 .12 -.17\u2020 \n1st/2nd Eye .28 .11 .23* \nStep 2    \nAge -.01 .01 -.11 \nSex -.20 .12 -.16\u2020 \n1st/2nd Eye .25 .11 .21* \nExtraversion/S .19 .08 .22* \nStep 3    \nAge -.01 .01 -.15 \nSex -.13 .11 -.11 \n1st/2nd Eye .18 .11 .15\u2020 \nExtraversion/S .09 .08 .11 \nFocus on Positive .35 .09 .35*** \nSeeking Support -.02 .10 -.02 \nActive Coping .16 .09 .18\u2020 \nEvasive Coping -.08 .16 -.05 \nNote. R2 = .11** for Step 1; \u2206R2  = .05* for Step 2; \u2206R2  = .13** for Step 3 . \u2020  p < .10, * p < .05, ** p < \n.01, *** p <.001.    \n \n \nTable D17 \nSummary of Hierarchical Regressi on Analysis for Variables Predicti ng Residualized Change of Positive \nAffect t1 to t2  \nPositive Affect t2 (n = 102) B SE B \u03b2 \nStep 1    \nPositive Affect t1 .68 .08 .67*** \nAge -.00 .01 -.04 \nSex -.07 .09 -.06 \n1st/2nd Eye .12 .09 .10 \nStep 2    \nPositive Affect t1 .66 .07 .66*** \nAge -.00 .01 -.01 \nSex -.07 .09 -.06 \n1st/2nd Eye .11 .08 .09 \nExtraversion/S .14 .06 .16* \nStep 3    \nPositive Affect t1 .62 .08 .62*** \nAge -.00 .01 -.03 \nSex -.06 .09 -.05 \n1st/2nd Eye .09 .09 .08 \nExtraversion/S .11 .06 .13 \nFocus on Positive .13 .08 .13\u2020 \nSeeking Support -.03 .08 -.03 \nActive Coping .04 .07 .05 \nDenial/Self-Blame -.10 .12 -.07 \nNote. R2 = .52*** for Step 1; \u2206R2  = .03\u2020 for Step 2; \u2206R2  = .02  for Step 3 . \u2020  p < .10, * p < .05, ** p < .01, \n*** p<.001.    \n \n \n \n \n                                                                                                                                              Appendices 294 \nTable D18 \nSummary of Hierarchical Regression Analysis for Variables Predicting Positive Affect t3  \nPositive Affect t3 (n = 101) B SE B \u03b2 \nStep 1    \nAge -.01 .01 -.08 \nSex -.30 .15 -.20* \n1st/2nd Eye .28 .14 .19\u2020 \nStep 2    \nAge -.00 .01 -.04 \nSex -.17 .16 -.12 \n1st/2nd Eye .28 .14 .19* \nNeuroticism/S -.26 .10 -.26* \nStep 3    \nAge -.01 .01 -.08 \nSex -.12 .15 -.08 \n1nd Eye .13 \nNeuroticism/S -.25 .11 \n.44 .36*** \n.13 \n.11 st/2 .19 .13 \n-.25* \nFocus on Positive .12 \nSeeking Support .05 .04 \nActive Coping .04 .03 \nEvasive Coping .05 .21 .03 \nNote. R2 = .09* for Step 1; \u2206R2  = .06* for Step 2; \u2206R2  = .14** for Step 3 . \u2020  p < .10, * p < .05, ** p < .01, \n*** p<.001.    \n \nTable D19 \nSummary of Hierarchical Regressi on Analysis for Variables Predicti ng Residualized Change of  Positive \nAffect t2 to t3  \nPositive Affect t3 (n = 101) \u03b2 B SE B \nStep 1    \nPositive Affect t2 .90 .09 .73*** \nAge .00 .01 \nSex -.11 .11 \n.03 \n \n.11 -.01 \n.07 \n-.03 \n.03 \n.14 \n-.11 \n.05 .03 \n-.08 \n1st/2nd Eye .10 .02 \nStep 2   \nPositive Affect t2 .88 .09 .71*** \nAge .05 .01 .06 \nSex -.02 \n1st/2nd Eye .03 .10 .02 \nNeuroticism/S -.20 -.20** \nStep 3    \nPositive Affect t2 .83 .10 .67*** \nAge .00 .01 .03 \nSex .11 -.02 \n1st/2nd Eye .10 .02 \nNeuroticism/S -.21 .08 -.21** \nFocus on Positive .10 .11 \nSeeking Support .05 .10 .04 \nActive Coping .08 -.10 \nEvasive Coping .11 .15 \nNote. R2 = .55*** for Step 1; \u2206R ep 2; \u2206R2  = .02  for Step 3 .  < .10, * p < .05, ** p < \n.01, *** p <.001.    2  = .03** for St\u2020  p\n Appendi ces 295 \n8.4.6. Neuroticism/S Predicts Longer-Term Outcomes: Directly and Indirectly  \n \nTable D20 \nSummary of Hierarchical Regression Analysis fo r Variables Predicting Depressive Symptoms t4  \nDepressive Symptoms (n = 94) B SE B \u03b2 \nStep1    \nAge -.05 \nMultimorbidity 1.69 \n \n1.27 \n.29 \n3.52 .82 \n.03 -.11 \nMultimorbidity 1.31 \n-2.48 \n1.07 \nActive Coping/D 1.49 .07 -.06 \nSex 2.30 1.33 .16\u2020 \nChange Visual Acuity S -.03 .03 -.08 \n.31 .51*** \nStep 2   \nAge -.08 .07 -.11 \nSex .85 .06 \nChange Visual Acuity S -.03 .03 -.09 \nMultimorbidity 1.36 .41*** \nNeuroticism/S .38*** \nStep 3    \nAge -.07 .06 -.09 \nSex 1.86 1.28 .13 \nChange Visual Acuity S -.04 \n.30 .40*** \nNeuroticism/S 3.35 .83 .36*** \nFocus on Positive/D .87 -.22** \nSeeking Support/D -1.49 -.13 \n.86 .16\u2020 \nDenial/Self-Blame/D 2.04 1.51 .13 \nNote. R2 = .34*** for Step 1; \u2206R2  = .11*** for Step 2; \u2206R2  = .08** for Step 3 . \u2020  p < .10, * p < .05, ** p < \n.01, *** p < .001 . ChangeVisual Acuity S =  Change in  best corrected distan ce visual acuity, eye \noperated on. \n \n8.4.7. Neuroticism/S Predicts Positive Aff ect: Directly and Indirectly via Selective \nCoping \n \nB \u03b2 Table D21 \nSummary of Hierarchical Regression Analysis for Variables Predicting Positive Affect t3  \nPositive Affect t3 (n = 101) SE B \nStep1    \nAge -.01 \n.15 \n \n-.00 \n-.12 \n.28 .14 \n \n.17\n.11 \nSelective Coping Sit.-Spec. .19 .01 -.08 \nSex -.29 .15 -.20\u2020 \n1st/2nd Eye .28 .19\u2020 \nMultimorbidity -.01 .04 -.04 \nStep 2   \nAge .01 -.04 \nSex -.18 .16 \n1st/2nd Eye .19* \nMultimorbidity .01 .04 .03 \nNeuroticism/S -.27 .11 -.27** \nStep 3   \nAge -.00 .01 -.03 \nSex -.14 .15 -.10 \n1st/2nd Eye .25 .14 \u2020 \nMultimorbidity .01 .03 .02 \nNeuroticism/S -.23 -.22* \n.53 .26** \nNote. R2 = .09\u2020 for Step 1; \u2206R2  = .06* for Step 2; \u2206R2  = .06** for Step 3 . \u2020  p < .10, * p < .05, ** p < .01, \n*** p < .001 .                                                                                                                                              Appendices 296 \nTable D22 \nSummary of Hierarchical Regression Analysis for Variables Predicting Positive Affect t3  \nPositive Affect t3 (n = 101) B SE B \u03b2 \nStep1    \nPositive Affect t2 .90 .73*** \n-.11 -.07 \n.11 \n.03 \n \nPositive Affect t2 .09 \n-.02 \n.10 \nMultimorbidity .03 \n \n.09 \n.01 .06 \n1 e .02 \n.08 .09 \nAge .00 .01 .03 \nSex .11 \n1st/2nd Eye .03 .02 \nMultimorbidity -.01 -.02 \nStep 2   \n.88 .71*** \nAge .01 .01 .05 \nSex -.02 .11 \n1st/2nd Eye .04 .02 \n.01 .03 \nNeuroticism/S -.21 .08 -.20** \nStep 3   \nPositive Affect t2 .84 .68*** \nAge .01 \nSex -.01 .11 -.01 \nst/2nd Ey .03 .10 \nMultimorbidity .01 .02 .03 \nNeuroticism/S -.19 -.19* \nSelective Coping Sit.-Spec .24 .14 .12\u2020 \nNote. R2 = .55*** for Step 1; \u2206R2  = .03* for Step 2; \u2206R2  = .01\u2020 for Step 3 . \u2020  p < .10, * p < .05, ** p < .01, \n*** p < .001.   \n \n \n8.4.8. Neuroticism/S Predicts Intensity of Li mitations at t1: Directly and Indirectly \nvia Total Range of Coping/D \n \nTable D23 \nSummary of Hierarchical Regression Analysis for Variables Predicting Intensity of Limitations t1 \nIntensity of Limitation t1 \u03b2 (last step) R \u2206R2 \nRival Predictors .28 - .08\u2020 \n2. Step Neuroticism/S .18\u2020 .35 .05* \n3. Step Total Range of Coping/D \nadded .03 .19\u2020 .40 \u2020 \nNote.  \u2020  p < .10, * p < .05, ** p < .01, *** p < .001. Rival predictors: Age, sex, pre-surgical visual acuity \nin the eye operated on. \n \n \n\u2206R \nTable D24 \nIntensity of Limitation Predicted by Neuroticism/ S, Dispositional Content Scales and Total Range of \nCoping \n \nIntensity of Limitation t1 \n  \nR 2 \n1. Step Rival Predictors .08\u2020 .28 \n2. Step Neuroticism/S .35 .05* \n3. Step Coping/D .41 .05\u2020 \n4. Step Total Range of Coping/D \nadded \n .42 .00 \nNote.  \u2020  p < .10, * p < .05, ** p < .01, *** p < .001. Rival predictors: Age, sex, pre-surgical visual acuity \nin the eye operated on. Appendi ces 297 \n8.5. Appendix E: Additional Information on Materials and Tests  \n8.5.1. Consent Form: Participation (German) \n \n \nVorname  ________________________ \n Erkl\u00e4rung zur freiwilligen Teilnahme an der Studie \u201eGrauer Star\u201c \nNachname _______________________ \nIch nehme freiwillig an der Studie \u201eGrauer Star\u201c teil und bin damit einverstanden, da\u00df \nmeine Angaben gespeichert werden. Meine Angaben werden ausschlie\u00dflich f\u00fcr \nwissenschaftliche Zwecke verwendet. \nIch kann diese Einwilligung jederzeit wieder zur\u00fcckziehen. \nBerlin/Mainz, den _________________ \n                                       (Datum) \nX________________________ \n               (Unterschrift) \n \n8.5.2. Consent Form: Participation (English)  \n \nConsent for Voluntary Participation in the Study \"Cataract\" \n \nLast Name ________________________ \nFirst Name  ________________________ \nI voluntarily participate in the study \"Cataract\". I give my consent that the information I \nprovide is saved. Said information is only used for scientific purposes. I can retract my \nconsent at any time.  \n \nBerlin/Mainz, _________________ \n                                 (Date) \nX________________________ \n           (Signature)                                                                                                                                              Appendices 298 \n8.5.3. Consent Form: Patient Confidentiality (German) \n \nErkl\u00e4rung zur \u00e4rztlichen Schweigepflicht \nNachname  _______________________ \nName der Klinik:  _______________________ \nIch kann diese Einwilligung jederzeit wieder zur\u00fcckziehen. Vorname ________________________ \nIch bin dam it einverstanden, da\u00df m ein operierender Augenarzt \nDr. _______________________ \ngegen\u00fcber den W issenschaftlern der Studie \u201eGrauer Star\u201c erg\u00e4nzende Angaben zu \nmeinem  Gesundheitszustand und zur Behandlung macht, und entbinde ihn/sie f\u00fcr diese \nAngaben von der \u00e4rztlichen Schweigepflicht. \nBerlin/Mainz, den _________________ \n                                       (Datum ) \nX________________________ \n               (Unterschrift) \n \n8.5.4. Consent Form: Patient Confidentiality (English) \n \nConsent for partial repeal of patient confidentiality \nLast Name _______________________ \nFirst Name ________________________ \nI consent in m y surgeon' s  \nDr. (Surgeons Name)  _______________________ \nHospital:  _______________________ \noffering additional inform ation on m y current  health status and treatm ent to the \nscientists conducting the \"Cataract\" study. Thus , I agree with the partial repeal of \npatient conf identiality. I can retract this consent at any tim e. \nBerlin/Mainz,  _________________ \n                                  (Date) \nX________________________ \n               (Signature) \n Appendi ces 299 \n8.5.5. The Brief COPE: German and English Versions (Carver, 1997) \nIm folgenden geht es darum, wie Sie sich in der letzten Woche gef\u00fchlt haben, wenn Sie  \nInstruction, Situation-Specific (t1): \nan die bevorstehende Operation dachten . Beurteilen Sie bitte, inwiefern die folgenden \nAussagen auf Ihr Denken und Handeln  in der letzten Woche  zutref fen. Bitte machen Sie \nf\u00fcr jede Aussage eine Angabe. \n(The next section deals with how you have felt during the past week  when you were \nthinking about the upcoming surgery . Please, rate how much each statement resembles \nyour thoughts and actions  during the past week . Please, endorse each item.)  \n \n \nInstruction, Dispositional (t4): \nBeurteilen Sie jetzt bitte, inwiefern die folgenden Aussagen auf Ihr Denken und \nHandeln in vergangenen unangenehmen oder schwierigen Situationen  zutreffen. Bitte \nmachen Sie f\u00fcr jede Aussage eine Angabe. \n(Please, rate how much each statement resembles your thoughts and actions in past \ndemanding or difficult situations . Please, endorse each item.) \n \nOriginal Two-Item Subscales: \n \n1. Self-distraction, items 1 and 19  \n2. Active coping, items 2 and 7  \n3. Denial, items 3 and 8  \n7. Behavioral disengagement, items 6 and 16  \n9. Positive reframing, items 12 and 17  \n 4. Substance use, items 4 and 11  \n5. Use of emotional support, items 5 and 15  \n6. Use of instrumental support, items 10 and 23  \n8. Venting, items 9 and 21  \n10. Planning, items 14 and 25  \n11. Humor, items 18 and 28  \n12. Acceptance, items 20 and 24  \n13. Religion, items 22 and 27  \n14. Self-blame, items 13 and 26  \n \nPossible Endorsements: \n \n(1) (2) (3) (4) \n\u00fcberhaupt nicht \n(not at all) ein bi\u00dfchen \n(a little bit) ziemlich \n(considerably) sehr \n(very much) \n \n Items:  \n1. Ich habe mich mit Arbeit oder anderen Sach en besch\u00e4ftigt, um auf andere Gedanken \nzu kommen. (I've been turning to work or other activities to take my mind off things.)                                                                                                                                                 Appendices 300 \n2. Ich habe m ich darauf konzentriert, et was an m einer Situation zu ver\u00e4ndern. (I've been \nconcentrating my efforts on doing something about the situation I'm in.)  \n \n6. Ich habe es aufgegeben, m ich dam it zu besch\u00e4ftigen. (I've been giving up trying to \ndeal with it.)  \n7. Ich habe aktiv gehandelt, um  die Situation zu verbessern. (I've been taking action to \ntry to make the situation better.)  \n10. Ich habe andere Menschen um  Hilfe und Rat gebeten. (I\u2019ve been getting help and \nadvice from other people.)  \n \n15. Jem and hat m ich getr\u00f6stet und m ir Verst\u00e4ndnis entgegengebracht. (I've been getting \ncomfort and understanding from someone.)  \n 3. Ich habe m ir eingeredet, da\u00df das alles nicht wahr ist. (I've been saying to myself \"this \nisn't real.\")  \n \n4. Ich habe Alkohol oder andere Mittel zu mir genom men, um  mich besser zu f\u00fchlen. \n(I've been using alcohol or other drugs to make myself feel better.)  \n \n5. Ich habe aufm unternde Unterst\u00fctzung von anderen erhalten. (I've been getting \nemotional support from others.)  \n \n \n \n8. Ich wollte einf ach nicht glauben, da\u00df m ir das passiert. (I've been refusing to believe \nthat it has happened.)  \n \n9. Ich habe m einen Gef\u00fchlen freien Lauf gelassen. (I've been saying things to let my \nunpleasant feelings escape.)  \n \n \n11. Um  das durchzustehen, habe ich m ich m it Alkohol oder anderen Mitteln bes\u00e4nftigt. \n(I've been using alcohol or other drugs to help me get through it.)  \n \n12. Ich habe versucht, die Dinge von ei ner positiveren Seite zu betrachten. (I've been \ntrying to see it in a different light, to make it seem more positive.)  \n13. Ich habe m ich selbst kritisiert und m ir Vorw\u00fcrfe gem acht. (I\u2019ve been criticizing \nmyself.)  \n \n14. Ich habe versucht, m ir einen Plan zu \u00fcberlegen, was ich tun kann. (I've been trying \nto come up with a strategy about what to do.)  \n \n \n16. Ich habe versucht, die Situa tion in den Griff zu kriegen. (r; English translation: I've \ntried to get the situation under control. Eng lish original: I've been giving up the attempt \nto cope.)  \n17. Ich habe versucht, etwas Gutes in dem zu finden, was m ir passiert ist. (I've been \nlooking for something good in what is happening.)  \n Appendi ces 301 \n18. Ich habe Witze dar\u00fcber gemacht. (I've been making jokes about it.) \n26. Ich habe mir f\u00fcr die Dinge, die mir wi derfahren sind, selbst die Schuld gegeben. \n(I\u2019ve been blaming myself for things that happened.) \n \n \n28. Ich habe alles mit Humor genommen. (I've been making fun of the situation.) \n  \n19. Ich habe etwas unternommen, um mich abzulenken. (I've been doing something to \nthink about it less.) \n  \n20. Ich habe mich damit abgefunden, da\u00df es passiert ist. (I've been accepting the reality \nof the fact that it has happened.) \n \n21. Ich habe offen gezeigt, wi e schlecht ich mich f\u00fchle. (I've been expressing my \nnegative feelings.) \n \n22. Ich habe versucht, Halt in  meinem Glauben zu finden. (I've been trying to find \ncomfort in my religion or spiritual beliefs.) \n \n23. Ich habe versucht, von anderen Me nschen Rat oder Hilfe einzuholen. (I\u2019ve been \ntrying to get advice or help from other people about what to do.) \n \n24. Ich habe gelernt, damit zu leben. (I've been learning to live with it.) \n \n25. Ich habe mir viele Gedanken dar\u00fcber gemacht, was hier das Richtige w\u00e4re. (I've \nbeen thinking hard about what steps to take.) \n \n27. Ich habe gebetet oder meditiert. (I've been praying or meditating.) \n                                                                                                                                              Appendices 302 \n8.5.6. The PANAS: German and English Versions (Watson, Clark, & Tellegen, \n1988) \n \nInstruction: German (English)  \n \nIm Anschlu\u00df finden Sie eine Liste von W\u00f6rtern, die unterschiedliche Gef\u00fchle \nbeschreiben. Bitte kreuzen Sie f \u00fcr jedes W ort an, wie sehr dieses Gef \u00fchl am heutigen \nTag auf Sie zutrif ft. Machen Sie bitte f \u00fcr jedes W ort eine Angabe. (Following this, you \nwill find a list of adjectives that describe d ifferent emotions. Please, endorse every item \naccording to how you have felt today. Please, endorse each item.)  \n \n \nTable E1 \n The PAN AS: Posi tive and N egative Af fect, Subf acets. \n \nPositive Affect  \n Negative Affect  \n \nEngl ish German Engl ish Subfacet \n \naktiv  \nactive   \nLow Fat igue  \nbetr\u00fcbt  \ndistressed  \nSadness \nmunter alert Low Fat igue besch\u00e4m t Guilt \nbefl\u00fcgelt schuldig guilty \nfreudi g erregt  Joviality \nenthusiastic  \nstark \nver\u00e4ngstigt Anxi ety \nattentive  \nAtten tiveness afraid ashamed \ninspired Joviality Guilt \nexcited aufgeregt upset  Anger \nbegei stert Joviality feindselig hostile Anger \nstrong Assurance reizbar irrita ble Anger \nstolz proud Assurance scared \nentschlossen determin ed  Assurance nerv\u00f6s nervous Anxi ety \naufm erksam  Attentiveness durcheinander jittery Anxi ety \ninteressiert interested  besorgt Anxi ety Germ an Subfacet \nNote. The Positive  and Negative Affect items were present ed in a different  order. It ems were rat ed on a 4-\npoint scal e: \u00fcberhaupt  nicht (not at all; 1), ein bi\u00dfchen (a little b it; 2), ziemlich (considerabl y; 3) , sehr \n(very much ;4) . The Positive and Negative Affect Schedul e (PANAS) by W atson, Clark, and Tellegen \n(1988). \n \n \n \n(Next, we would like for you to rate, how ea sy or difficult the pursuit of a number of \nactivities is for you at the moment, if you wear  your glasses or make use of other vision \naids. You can choose between a number of options: very easy, easy, undecided, difficult, 8.5.7. Assessment of Vision-Related Functi onal Status (after Javitt et al., 1997) \n \nInstruction German (English)  \n \nIm folgenden m \u00f6chten wir Sie bitten einz usch\u00e4tzen, wie schwierig oder wie leicht \nmomentan verschiedene Aktivit\u00e4ten f\u00fcr Si e sind, wenn Sie eine Brille oder sonstige \nSehhilfen benutzen. Sie k\u00f6nnen hierbei zwis chen den folgenden Aussagen w\u00e4hlen: sehr \nleicht, leicht, schwierig, sehr schwierig . Wenn Sie eine der Aktivit\u00e4ten gar nicht \naus\u00fcben, m achen Sie daf \u00fcr bitte ein Kreuz in der ganz rechten Spalte. Bitte lassen Sie \nkeine Zeile aus und m achen Sie f\u00fcr jede der folgenden Aktivit\u00e4ten eine Angabe. \n Appendi ces 303 \nvery difficult. If you do not at all pursue a given activity, please mark the column to the \nvery right. Please, try not to skip a line and endorse each item.) \nTable E2  \nItems after the Cataract TyPE Spec ification by Javitt and Colleagues (1997) \nGerman English \n1.  Rasieren oder Schminken Shaving or putting on make-up \n2.  Alltagsverrichtungen (Einkauf, \nHaushalt etc.) \nVisiting friends or family \nReading (newspapers, books) \nReading street signs \n10. Autofahren: tags\u00fcber Usual daily activities (grocery shopping, \ncleaning) \n3.   Hobbies Hobbies \n4.   Theater-/Kinobesuche Going to the movies or theater \n5.   Freunde/Verwandte besuchen  \n6.   Sport treiben Sports \n7.   Lesen (Zeitschriften, B\u00fccher, etc.) \n8.   Fernsehen Watching TV \n9.   Stra\u00dfenschilder lesen \nDaytime driving \n11. Autofahren: nachts Nighttime driving \n \n ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}